Eurofins CDMO Alphora Integrates Continuous Flow Tech to Boost API Manufacturing

Event summary

  • Eurofins CDMO Alphora has integrated custom-built Continuous Flow (CF) technology into its API manufacturing operations.
  • The project is supported by advisory services and R&D funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
  • The new CF equipment line was developed in-house by Eurofins CDMO Alphora scientists in collaboration with a local university.
  • The technology enables substantial intensification of complex manufacturing processes traditionally difficult to scale in batch mode.
  • Eurofins CDMO Alphora has over 250 employees and operates an FDA, Health Canada, and Japan PMDA inspected site.

The big picture

The integration of Continuous Flow technology into API manufacturing represents a strategic shift towards more efficient, scalable, and sustainable production methods. This move aligns with broader industry trends towards process intensification and operational agility, particularly for high-value, technically challenging APIs. Eurofins CDMO Alphora’s collaboration with NRC IRAP and a local university underscores the growing importance of public-private partnerships in driving innovation within the pharmaceutical manufacturing sector.

What we're watching

Technology Adoption
How quickly Eurofins CDMO Alphora can scale the Continuous Flow technology across its API manufacturing portfolio.
Competitive Positioning
Whether the integration of CF technology will enhance Eurofins CDMO Alphora’s market position against other CDMOs.
Regulatory Compliance
The pace at which regulatory bodies will adapt to and approve the use of Continuous Flow technology in API manufacturing.